Literature DB >> 30805758

Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarction.

Aloysius Sheng-Ting Leow1, Ching-Hui Sia2, Benjamin Yong-Qiang Tan3, Rajinderdeep Kaur2, Tiong-Cheng Yeo2,4, Mark Yan-Yee Chan2,4, Edgar Lik-Wui Tay2,4, Raymond Chee-Seong Seet3,4, Joshua Ping-Yun Loh2,4, Leonard Leong-Litt Yeo3,4.   

Abstract

Acute ischemic stroke (AIS) is a feared complication in post-acute myocardial infarction (AMI) patients who develop left ventricular (LV) thrombus. There is limited data available on the incidence of stroke in this population, and characterisation of stroke subtypes has not been previously reported. Our study aims to evaluate the incidence of AIS in post-AMI patients with LV thrombus and to characterise the pattern of stroke subtypes. We screened 5829 patients with echocardiogram reports containing the "thrombus" keyword from August 2006 to September 2017. AIS that occurred after LV thrombosis was captured and relevant clinical data was collected. We identified 289 post-AMI patients with acute LV thrombus formation. Mean age was 59.3 ± 13.4 years. AIS occurred in 34 patients (11.8%), median duration of 20.5 days (IQR = 5.5-671.8) after LV thrombosis. Despite initial thrombus resolution, nine (5.2%) encountered AIS subsequently. Cardioembolic stroke subtype was identified in 76.5% of AIS, whilst 14.7% was small vessel disease and 8.8% was of large artery atherosclerosis subtype. Presence of thrombus protrusion (HR 3.04, 95% CI 1.25-7.41, p = 0.01), failure of initial thrombus resolution (HR 3.03, 95% CI 1.23-7.45, p = 0.02) and thrombus recurrence (HR 4.20, 95% CI 1.46-12.11, p < 0.01) were significant independent predictors for stroke. Incidence of AIS in this Asian population of post-AMI patients with LV thrombus was 11.8%. Duration of anticoagulation may need to be individualised for patients with higher risk for stroke occurrence after LV thrombosis.

Entities:  

Keywords:  Acute ischemic stroke; Acute myocardial infarction; Anticoagulation; Cardioembolism; Left ventricular thrombus

Year:  2019        PMID: 30805758     DOI: 10.1007/s11239-019-01829-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  6 in total

1.  Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi.

Authors:  Yehia Saleh; Abdullah Al-Abcha; Ola Abdelkarim; Mahmoud Abdelnabi; Abdallah Almaghraby; Neal S Kleiman
Journal:  Am J Cardiovasc Drugs       Date:  2021-11-05       Impact factor: 3.571

2.  Concurrent Coronary, Left Ventricle, and Cerebral Thrombosis - A Trilogy.

Authors:  Monika Bhandari; Akshyaya Kumar Pradhan; Pravesh Vishwakarma; Rishi Sethi
Journal:  Int J Appl Basic Med Res       Date:  2022-05-10

Review 3.  Management of left ventricular thrombus: a narrative review.

Authors:  Jose B Cruz Rodriguez; Kazue Okajima; Barry H Greenberg
Journal:  Ann Transl Med       Date:  2021-03

4.  Pathogenetic Link of Cardiac Rupture and Left Ventricular Thrombus Following Acute Myocardial Infarction: A Joint Preclinical and Clinical Study.

Authors:  Shan Ma; Ling Bai; Ping Liu; Gang She; Xiu-Ling Deng; An-Qi Song; Xiao-Jun Du; Qun Lu
Journal:  Front Cardiovasc Med       Date:  2022-06-09

5.  Predicting mortality, thrombus recurrence and persistence in patients with post-acute myocardial infarction left ventricular thrombus.

Authors:  Wesley Yeung; Ching-Hui Sia; Tom Pollard; Aloysius Sheng-Ting Leow; Benjamin Yong-Qiang Tan; Rajinderdeep Kaur; Tiong-Cheng Yeo; Edgar Lik-Wui Tay; Leonard Leong-Litt Yeo; Mark Yan-Yee Chan; Joshua Ping-Yun Loh
Journal:  J Thromb Thrombolysis       Date:  2021-01-02       Impact factor: 2.300

6.  To treat or not to treat: left ventricular thrombus in a patient with cerebral amyloid angiopathy: a case report.

Authors:  Alexander D Hilt; Ingeborg Rasing; Martin J Schalij; Marieke J H Wermer
Journal:  Eur Heart J Case Rep       Date:  2020-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.